1. Главная
  2. Ресурсы
  3. Библиотечный поиск
Prognostic factorsfor relapsedchildhood acutelymphoblasticleukemia: Impact ofallogeneic stem celltransplantation—areport from theKyushu-Yamaguchi… Akinobu MatsuzakiYoshihisa NagatoshiHiroko Inada2005 год

Prognostic factors for relapsed childhood acute lymphoblastic leukemia: Impact of allogeneic stem cell transplantation—a report from the Kyushu-Yamaguchi Children's Cancer Study Group
статья из журнала

Страница публикацииПубликация в OpenAlex
Аннотация: Background The treatment results of childhood acute lymphoblastic leukemia (ALL) with a first relapse were retrospectively analyzed to determine prognostic factors. In particular, an attempt was made to clarify whether stem cell transplantation (SCT) had any advantages over chemotherapy. Procedures Of the 407 children with ALL diagnosed between 1984 and 1996, 117 suffered from a relapse before December 1999. The patients were treated differently according to the protocols of each institution. The potential prognostic factors examined were: the time of initial diagnosis, gender, immunophenotype of leukemic blasts and the NCI-risk classification at initial diagnosis, the site of relapse, the time of relapse (early: within 18 months after diagnosis, intermediate: other than either early or late relapse, late: later than 6 months after the discontinuation of front-line chemotherapy), and the treatment after relapse (chemotherapy alone and SCT). Results A second complete remission (CR2) was achieved in 90 patients (77%) and thirty of them maintained CR2, thus resulting in an event-free survival rate (EFS) of 25.1% and an overall survival rate of 26.1%. The significant prognostic factors identified by a multivariate analysis included the time of relapse (EFS: early 16.2%, intermediate 23.9%, late 35.1%, P = 0.012) and the treatment after relapse (EFS: SCT 30.3%, chemotherapy 22.0%, P = 0.049). When patients with an isolated bone marrow relapse and continuous CR2 for more than 3 months were analyzed, the treatment in CR2 was the only independent prognostic factor (EFS: SCT 60.2%, chemotherapy 25.7%, P = 0.005). Conclusions In children with ALL and a first relapse, the time of relapse and the treatment after relapse were found to be independent prognostic factors. Allogeneic SCT in CR2 showed significantly better results than chemotherapy in patients with an isolated bone marrow relapse. Pediatr Blood Cancer © 2005 Wiley-Liss, Inc.
Год издания: 2005
Авторы: Akinobu Matsuzaki, Yoshihisa Nagatoshi, Hiroko Inada, Hideki Nakayama, Fumio Yanai, Hiroshi Ayukawa, Kiyoshi Kawakami, Hiroshi Moritake, Aiko Suminoe, Jun Okamura
Издательство: Wiley
Источник: Pediatric Blood & Cancer
Ключевые слова: Acute Lymphoblastic Leukemia research, Childhood Cancer Survivors' Quality of Life, Hematopoietic Stem Cell Transplantation
Другие ссылки: Pediatric Blood & Cancer (HTML)
PubMed (HTML)